XORTX Therapeutics Inc. Fee And Commission Expense
XORTX Therapeutics Inc. (XRTX) reported Fee And Commission Expense of CAD 236.80 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Operating Expenses
ifrs-full:FeeAndCommissionExpense · last filed 2022-05-03
| Period end | Fee And Commission Expense 12 month |
|---|---|
| 2021-12-31 | 236.80K CAD 20-F · filed 2022-05-03 |
| 2020-12-31 | 52.14K CAD 20-F · filed 2022-05-03 |
| 2019-12-31 | 42.49K CAD 20-F · filed 2022-05-03 |